US Patent 10302663 Method of assessing pancreatic beta-cell function
Patent 10302663 was granted and assigned to Metabolon on May, 2019 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 10302663 Method of assessing pancreatic beta-cell function
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.